The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity

Nephrology Dialysis Transplantation

Volumn 13, Issue 1, 1998, Pages 173-176

  Nabokov, Alexander ^a   Amann, Kerstin ^a   Gassmann, Peter ^a   Schwarz, Ute ^a   Orth, Stephan R ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin converting enzyme inhibitor; Bradykinin; Glomerulosclerosis; Remnant kidney model; Renal failure

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; KININ; RAMIPRIL;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; MALE; NEPHRECTOMY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; KIDNEY; KIDNEY FAILURE, CHRONIC; KININS; MALE; RAMIPRIL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ;

EID: 0031973279     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.1.173     Document Type: Article

References (27)

1. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-619
2. Anderson S, Rennke HG, Garcia DL, Brenner BM. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989; 36: 526-536
3. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1994; 46: 396-404
4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
5. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945
6. Hilgers KF, Mann JFE. Role of angiotensin II in glomerular injury: Lessons from experimental and clinical studies. Kidney Blood Press Res 1996; 19: 254-262
7. Campbell DJ, Kladis A, Duncan A-M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994; 23: 439-449
8. Verma PS, Gagnon JA, Miller RL. Intrarenal kallikrein-kinin activity in acute renovascular hypertension in dogs. Renal Physiol Biochem 1987; 10: 311-317
9. Ichikawa I. Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int 1996; 50: 684-692
10. Amann K, Irzyniec T, Mall G, Ritz E. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis. J Hypertens 1993; 11: 969-975
11. El Nahas AM, Bassett AH, Cope GH, Carpentier JE. Role of growth hormone in the development of experimental renal scarring. Kidney Int 1991; 40: 29-34
12. Véniant M, Heudes D, Clozel J-P, Bruneval P, Ménard J. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidney Int 1994; 46: 421-429
13. Kon V, Fogo A, Ichikawa I. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int 1993; 44: 545-550
14. Hutchison FN, Cui X, Webster SK. The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin. J Am Soc Nephrol 1995; 6: 1216-1222
15. Hutchison FN, Webster SK. Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis. Am J Physiol 1992; 263: F311-F318
16. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 1994; 45: 537-543
17. Matsuda H, Hayashi K, Arakawa K et al. Heterogeneity in Ace-I stimulated bradykinin action in superficial (Sc) and juxtamedullary (JM) arterioles in in vivo dogs. J Am Soc Nephrol 1996; 7: 1585 (Abstract)
18. Lafayette RA, Mayer G, Park SK, Meyer TW. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992; 90: 766-771
19. Ziai F, Ots M, Provoost AP et al. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Kidney Int 1996: 50 [Suppl 57]: S132-S136
20. Remuzzi A, Perico N, Amuchastegui CS et al. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993; 4: 40-49
21. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp Nephrol 1996; 4: 19-25
22. Meyer TW, Anderson S, Rennke HG, Brenner BM. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987; 31: 752-759
23. Lee SK, Jin SY, Han DC, Hwang SD, Lee HB. Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats. Nephrol Dial Transplant 1993; 8: 1338-1343
24. Shibahara H, Okada K, Yanai M, Kuno T, Kanmatsuse K, Takahashi S. Effect of angiotensin-converting enzyme inhibitor in rats with established chronic renal failure. Nephrol Dial Transplant 1996; 11: A131 (Abstract)
25. Shibahara H, Okada K, Takahashi S, Kanmatsuse K, Sugino N, Shimamura T. Administration of angiotensin-converting enzyme inhibitor and oral adsorbent in rats with established chronic renal failure. J Am Soc Nephrol 1996; 7: 1864 (Abstract)
26. Gretz N, Waldherr R, Strauch M. The remnant kidney model. In: Gretz N, Strauch M, eds. Experimental and Genetic Rat models of Chronic Renal Failure. Karger, Basel, 1993; 1-28
27. Nakamura T, Obata J, Ohno S, Yoshida Y, Kawachi H, Shimizu F. Blocking angiotensin II reduces proteinuria, glomerulosclerosis, glomerular expression of transforming growth factor-β and type I and III collagens in rat progressive mesangioproliferative glomerulonephritis. J Am Soc Nephrol 1996; 7: 1741 (Abstract)